Fidelity Investments’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31 Sell
2
-12
-86% -$198 ﹤0.01% 5470
2026
Q1
$239 Buy
+14
New +$248 ﹤0.01% 5217
2025
Q4
Sell
-4
Closed -$84 5508
2025
Q3
$84 Buy
+4
New +$79 ﹤0.01% 5213
2025
Q2
Sell
-140
Closed -$2.19K 5422
2025
Q1
$2.19K Buy
+140
New +$2.05K ﹤0.01% 4866
2022
Q3
Sell
-491
Closed -$11K 5186
2022
Q2
$11K Buy
+491
New +$10.3K ﹤0.01% 4088
2021
Q2
Sell
-1
Closed 4595
2021
Q1
$0 Buy
+1
New +$41 ﹤0.01% 4294

Other funds holding KURE

Fidelity Investments's KURE Position: Q2 2026 in Review

Fidelity Investments reduced its KraneShares MSCI All China Health Care Index ETF (KURE) stake by 86% in Q2 2026, selling an estimated $198 and leaving 2 shares worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #5470.

Fidelity Investments first reported a position in KURE in Q1 2021 and has held it in 6 quarters since. The position peaked at $11K in Q2 2022. 13 funds tracked by Wall St. Rank hold KURE as of Q2 2026.

  • Fidelity Investments held 2 shares of KraneShares MSCI All China Health Care Index ETF worth $31 as of Q2 2026.
  • Fidelity Investments sold 12 KraneShares MSCI All China Health Care Index ETF shares in Q2 2026, an estimated $198.
  • KraneShares MSCI All China Health Care Index ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5470 holding.
  • Fidelity Investments first reported a position in KraneShares MSCI All China Health Care Index ETF in Q1 2021 and has held it in 6 quarters since.
  • Fidelity Investments's KraneShares MSCI All China Health Care Index ETF position peaked at $11K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.